Medicare Enrolled

Dr. Yemane Bahta, MD

Infectious Disease · Pembroke Pines, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
10794 PINES BLVD, Pembroke Pines, FL 33026
9543925696
In practice since 2006 (19 years)
NPI: 1316020316 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bahta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bahta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bahta

Dr. Yemane Bahta is an infectious disease specialist in Pembroke Pines, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bahta performed 698 Medicare services across 289 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bahta received a total of $3,909 from 17 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bahta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 698 Medicare services $3,909 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 71889 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
698
Medicare services
Bottom 36% in FL for infectious disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
289
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 329 $65 $251
Hospital follow-up visit, high complexity 208 $97 $300
Initial hospital admission, high complexity 141 $142 $350
Office visit, established patient, complex (40-54 min) 20 $145 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,909
Total received (2018-2024)
Avg $558/year across 7 years
Top 25% in FL for infectious disease
17
Companies
144
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,909 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$983
2023
$428
2022
$435
2021
$750
2020
$222
2019
$583
2018
$508

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ViiV Healthcare Company
$1,797
Allergan Inc.
$469
ABBVIE INC.
$369
AbbVie Inc.
$238
Shionogi Inc
$201
Merck Sharp & Dohme Corporation
$199
Dexcom, Inc.
$144
Merck Sharp & Dohme LLC
$141
Insmed, Inc.
$80
Gilead Sciences, Inc.
$79
La Jolla Pharmaceutical Company
$49
Allergan, Inc.
$39
Vyera Pharmaceuticals, LLC
$33
Paratek Pharmaceuticals, Inc.
$24
TETRAPHASE PHARMACEUTICALS, INC.
$23
Mylan Pharmaceuticals Inc.
$12
Mylan Institutional Inc.
$11
Top 3 companies account for 67.4% of total payments
Associated products mentioned in payments ›
AVYCAZ · Arikayce · CABENUVA · Cimduo · DALVANCE · DEXCOM G7 GSS (161) · DOVATO · Daraprim 30 Tablet in 1 Bottle · Daraprim Tablet 25mg · Fetroja · ISENTRESS · JULUCA · NUZYRA · PIFELTRO · PREVYMIS · Symfi Lo · TEFLARO · TRIUMEQ · XACDURO · Xerava · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $560 per 100 Medicare services performed
Looking for an infectious disease specialist in Pembroke Pines?
Compare infectious diseases in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
162
Per 100K population
8.3
County median income
$74,534
Nearest hospital
SOUTH FLORIDA STATE HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bahta is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bahta experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bahta performed 329 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bahta receive payments from pharmaceutical companies?
Yes. Dr. Bahta received a total of $3,909 from 17 companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bahta's costs compare to other infectious diseases in Pembroke Pines?
Dr. Bahta's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bahta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →